There are no upcoming events at this time.

View All
View Full Calendar See All Updates

Get Email Updates

Energy and Commerce Committee

Letter

Filters
Sort Content By:
Subcommittees
Post Types
Categories

Letter requesting follow-up hearing on maternal mortality

10.15.2019

Excerpt: "Despite massive innovation in health care and advancements in technology, over the last two decades, the number of American women who die each year from a pregnancy-related cause has increased dramatically," wrote Walden, Burgess, Guthrie, and Bucshon.

Click here to read the letter.

Letter

Letter calling for second hearing on partisan Pelosi plan

10.15.2019

Excerpt: "Given the testimony heard in the subcommittee hearing and the implications H.R. 3 could have on denying treatments and next generation cures to our constituents, this process must not be rushed," Walden and Burgess write.

Click here to read the letter.

Letter

Letter to Drug Enforcement Administration on Report Recommendations

10.11.2019

Excerpt: "As Members of the House Energy and Commerce Committee and leaders of an investigation into opioid distribution, we are following up on the status of recommendations directed to the Drug Enforcement Administration (DEA) to address concerns outlined in the December 19, 2018 report, Red Flags and Warning Signs Ignored: Opioid Distribution and Enforcement Concerns in West Virginia,"  Walden, Guthrie, and McKinley write in their letter to the DEA.

Click here to read the letter.

Letter

Letters to Opioid Distributors on Report Recommendations

10.11.2019

Excerpt: "While this report focused on a series of missteps and missed opportunities that contributed to the worsening of the opioid epidemic in West Virginia, the report raised grave concerns about distributors’ compliance programs nationwide. The report included recommendations to improve distributors’ programs. In addition, the recently enacted SUPPORT for Patients and Communities Act included several provisions to respond to these concerns," the lawmakers continue in their letters to the distributors.

Click here to read the letter to AmerisourceBergen.

Click here to read the letter to Cardinal Health.

Click here to...

Letter

Letters to States on Use of Federal Funds to Respond to Opioid Crisis

09.19.2019

“States are on the front lines of this battle. The continued magnitude of overdose deaths indicates that there is more work to be done, and continued federal, state, and local coordination and support is needed to combat this daunting crisis,”  the bipartisan Committee leaders wrote.

Click here to read the Florida letter.

Click here to read the Indiana letter.

Click here to read the Kentucky letter.

Click here to read the Maine letter.

Click here to read the Maryland letter.

Click here to read the Massachusetts letter.

Click here...

Letter

Letter to private equity firms regarding surprise billing

09.16.2019

Excerpt: "Evidence indicates that these physician staffing firms charge significantly higher in-network rates than their counterparts, thereby driving reimbursement upwards as they enter into staffing arrangements with hospitals. We are concerned about the increasing role that private equity firms appear to be playing in physician staffing in our nation’s hospitals, and the potential impact these firms are having on our rising health care costs," said Pallone and Walden.

Click here to read the letter to KKR & Co. Inc.

Click here to read the letter to Blackstone Group.

Click...

Letter

Letter to HHS Assistant Secretary for Health Requesting Update on SUPPORT Act Implementation

08.28.2019

Excerpt: "This dashboard was intended to be an easily accessible electronic hub for the public, providing links to information on programs within HHS related to the reduction of opioid and other substance use disorders, along with access to the publicly available data from HHS agencies and other relevant entities such as medical experts, nonprofit organizations, law enforcement, and research institutions. The dashboard also was supposed to provide data on substance use disorder prevention and treatment strategies in different regions of and populations in the United States, identify information on...

Letter

Letter to GAO Comptroller General Gene Dodaro Requesting Examination of DHS’s New Biosurveillance Pilot Program

08.08.2019

Excerpt: “We write to request that the Government Accountability Office examine the Department of Homeland Security’s deployment of a new biodetection technology system called BioDetection 21 to replace BioWatch, and the status of the DHS’s implementation of GAO’s prior recommendations concerning BioWatch.

...

This Committee has an ongoing bipartisan interest in biosurveillance programs that involve the Centers for Disease Control and Prevention, and the state and local public health laboratories.”

 

To read the full letter, click here.

Letter
Letter